TransMedics Group, Inc. financials

  1. Home
  2. Financials
  3. TMDX
TMDX CIK 0001756262

Source: EDGAR filings · Built 2026-06-02T04:11:24Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 133.59M -80.94M -164.88M -57.72M -32.38M -30.72M
EBITDA 135.77M 57.25M -20.55M -27.96M -37.61M —
Working Capital 548.48M 437.30M 455.72M 228.63M 95.47M 134.89M
Net Debt 20.91M 181.64M 121.13M -133.63M 18.22M 10.08M
Gross Margin 59.92% 59.36% 63.77% 69.84% 67.42% 58.66%
Operating Margin 17.93% 8.49% -11.89% -33.64% -125.63% -93.05%
Net Margin 31.43% 8.03% -10.36% -38.77% -140.88% -101.38%
Return on Equity (ROE) 40.22% 15.51% -18.24% -19.34% -65.16% -27.67%
Return on Assets (ROA) 17.81% 4.41% -3.54% -13.07% -32.78% -18.91%
Current Ratio 7.14× 8.30× 9.30× 10.66× 5.11× 12.36×
Debt-to-Equity 1.08× 2.27× 3.76× 0.36× 0.65× 0.33×
Effective Tax Rate -76.98% 0.88% 6.16% -0.18% — 0.00%
Cash Conversion Ratio 1.01× 1.38× 0.52× 1.26× 0.65× 1.05×
Accruals Ratio -0.00× -0.02× -0.02× 0.03× -0.11× 0.01×
SBC % of Revenue 6.09% 7.52% 8.19% 11.04% 21.91% 8.51%
CapEx Coverage 3.25× 0.38× -0.09× -3.85× -8.20× -66.52×
Free Cash Flow Per Share $3.30 $-2.30 $-5.07 $-1.95 $-1.17 $-1.24

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 24.98× 61.73× — — — —
P/FCF 36.92× — — — — —
FCF Yield 2.71% — — — — —
EV / EBITDA 30.86× 39.78× — — — —
P/S 6.88× 4.75× 10.67× 21.23× 16.97× 19.07×
P/B 8.81× 9.17× 18.80× 10.59× 7.85× 5.21×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax — — — — 31.39M 28.36M
Revenues 605.49M 441.54M 241.62M 93.46M 30.26M 25.64M
Cost of Revenue 242.69M 179.46M 87.53M 28.19M 9.10M 9.00M
Gross Profit 362.81M 262.08M 154.09M 65.27M 21.16M 16.64M
Research and Development Expense 69.06M 55.97M 36.05M 26.81M 22.30M 18.83M
Selling, General and Administrative Expense 185.17M 168.62M 119.55M 69.90M 38.28M 24.19M
Operating Expenses 254.22M 224.59M 182.82M 96.71M 60.59M 43.02M
Operating Income (Loss) 108.58M 37.50M -28.73M -31.44M -39.43M -26.38M
Income Tax Expense (Benefit) -82.77M 316.00K -1.64M 66.00K — 0
Net Income (Loss) Attributable to Parent 190.29M 35.46M -25.03M -36.23M -44.22M -28.75M
Earnings Per Share, Basic $5.60 $1.07 $-0.77 $-1.23 $-1.60 $-1.16
Weighted Average Number of Shares Outstanding, Basic 33.99M 33.23M 32.52M 29.56M 27.62M 24.70M
Earnings Per Share, Diluted $4.87 $1.01 $-0.77 $-1.23 $-1.60 $-1.16
Weighted Average Number of Shares Outstanding, Diluted 40.54M 35.22M 32.52M 29.56M 27.62M 24.70M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value — — 394.81M 201.18M 25.58M 24.58M
Assets, Current 637.78M 497.22M 510.65M 252.29M 118.70M 146.77M
Assets 1.07B 804.08M 706.05M 277.15M 134.89M 152.03M
Liabilities, Current 89.31M 59.91M 54.93M 23.66M 23.24M 11.88M
Long-term Debt, Excluding Current Maturities — — — 58.70M 35.20M 34.66M
Liabilities 595.27M 575.47M 568.85M 89.77M 67.04M 48.13M
Stockholders' Equity Attributable to Parent 473.10M 228.60M 137.20M 187.38M 67.85M 103.89M
Common Stock, Shares, Outstanding 34.27M 33.62M 32.67M 32.14M 27.79M 27.18M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 192.84M 48.80M -13.03M -45.82M -28.86M -30.27M
Payments to Acquire Property, Plant, and Equipment 59.25M 129.74M 151.85M 11.91M 3.52M 455.00K
Net Cash Provided by (Used in) Investing Activities -59.25M -129.30M -193.95M 54.51M 29.27M -41.60M
Net Cash Provided by (Used in) Financing Activities 16.86M 22.87M 400.42M 167.93M 1.39M 75.55M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (TMDX CIK 0001756262), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

THFF

FIRST FINANCIAL CORPORATION

COCO

The Vita Coco Company, Inc.

LWLG

Lightwave Logic, Inc.